MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

23 Oct 2024 Evaluate
The sales for the September 2024 quarter moved down to Rs. 97.64 millions as compared to Rs. 115.28 millions during the year-ago period.Net Profit of the company move down -52.42% to Rs. 13.48  millions from Rs. 28.33 millions  in the same quarter last year.A decline of 27.49 millions was observed in the OP in the quarter ended September 2024 from 57.04 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 97.64 115.28 -15.30 196.77 207.84 -5.33 408.34 424.24 -3.75
Other Income 3.44 1.93 78.24 6.81 3.94 72.84 10.04 10.84 -7.38
PBIDT 27.49 57.04 -51.81 65.22 95.71 -31.86 182.26 217.87 -16.34
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.12 0.00
PBDT 40.97 57.04 -28.17 78.70 95.71 -17.77 182.26 216.75 -15.91
Depreciation 17.46 18.07 -3.38 34.73 36.08 -3.74 70.85 71.73 -1.23
PBT 23.51 38.97 -39.67 43.97 59.63 -26.26 111.41 145.02 -23.18
TAX 10.03 10.64 -5.73 17.59 16.86 4.33 28.43 29.17 -2.54
Deferred Tax 10.03 10.64 -5.73 17.59 16.86 4.33 28.43 29.17 -2.54
PAT 13.48 28.33 -52.42 26.38 42.77 -38.32 82.98 115.85 -28.37
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 28.15 49.48 -43.10 33.15 46.05 -28.02 44.63 51.36 -13.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..